The Economic Times

IMA seeks specialist-only prescriptions amid misuse risks and cheap generics of GLP-1 weight-loss drugs

The Indian Medical Association is seeking government intervention to regulate GLP-1 weight-loss drugs. Concerns are rising over their misuse by various practitioners for cosmetic weight loss. The IMA advocates for restricting prescriptions to specialists to ensure patient safety. This move comes as cheaper generic versions are expected to enter the market, potentially widening access and risks.